Neurology & Neurosurgery Research
ASPIRE Study
Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery (ASPIRE)
AGE: 18 years and older
SEX AT BIRTH: All
SEX AT BIRTH: All
TYPE: Investigational Drug Study
CONDITION: Brain Hemorrhage
CONDITION: Brain Hemorrhage
HEALTHY PARTICIPANTS: No
LOCATION: UH Cleveland Medical Center
LOCATION: UH Cleveland Medical Center
Learn More About This Research Study
For more information, please contact study coordinator, Mary Andrews at 216-844-2386 and leave a message or complete the online form below.
Study Purpose
The purpose of this research study is to compare the effects of apixaban (also known as Eliquis®) with aspirin in patients with atrial fibrillation and a recent brain hemorrhage to see which is better in preventing strokes and death.
Who Can Participate
Participants 18 years and older experienced an intracerebral hemorrhage may be eligible for this study.